Quick Summary:
Discover untapped opportunities within the Immunohematology Analyzers and Reagents industry with our comprehensive market research report. From a respectable US$2 Billion in 2022, the global market is estimated to skyrocket, reaching an impressive US$2.9 Billion by 2030. To stay ahead in this fast-paced and competitive market, allow our report to guide your business strategies and help you make data-driven decisions.
Featuring thorough analysis on key players like Immucor, Inc., Merck & Co., Inc., Siemens Healthineers, among others, our report presents an in-depth scan of the market landscape. With extensive coverage of diverse geographic markets, such as the rapidly growing markets of the U.S. and China, our report empowers you to leverage emerging trends and create innovative solutions. Stay ahead of the competitive curve in the Immunohematology Analyzers and Reagents industry with insights that are both relevant and actionable.
Global Immunohematology Analyzers and Reagents Market to Reach $2.9 Billion by 2030
The global market for Immunohematology Analyzers and Reagents estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$2.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analyzers segment is readjusted to a revised 5.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $610.5 Million, While China is Forecast to Grow at 4.4% CAGR
The Immunohematology Analyzers and Reagents market in the U.S. is estimated at US$610.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$519 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.Select Competitors (Total 12 Featured) -
- Immucor, Inc.
- Merck & Co., Inc.
- Merck KgaA
- Ortho Clinical Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Grifols SA
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Immunohematology Analyzers and Reagents?
What is the growth rate of the Global Market for Immunohematology Analyzers and Reagents?
What is the forecasted size of the Global Market for Immunohematology Analyzers and Reagents?
Who are the key companies in the Global Market for Immunohematology Analyzers and Reagents?
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2 Billion |
| Forecasted Market Value ( USD | $ 2.9 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Immucor, Inc.
- Merck & Co., Inc.
- Merck KgaA
- Ortho Clinical Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Grifols SA
